Drug companies are still focused on raising prices, but some in the industry realize things need to change
- The US spends far more than other industrialized countries on health care. But Americans, on a per-person basis, don't go to the doctor or hospital more than people in other wealthy nations.
- Health care companies, even not-for-profits like hospitals that don't have typical investors, have prioritized meeting revenue and profitability goals.
- That suggests that pricing practices won't change any time soon.
Health care executives gave no indication to bankers and investors at this year's J.P. Morgan Healthcare Conference that their pricing practices would change any time soon.
Why it matters: That sentiment comes the same week when three of the original authors of an influential 2003 article - which studied why health care is so expensive in the U.S.- published an update. Their conclusion was the same: "It's still the prices, stupid."
- A Google engineer found out she had been laid off while she was on vacation when her boss sent her a LinkedIn message
- A laid-off Microsoft software engineer on an H1-B visa said she wonders 'where will I be living' with just 60 days to find a new job
- Laid-off Google employees are turning to a Discord server with nearly 18,000 members for emotional support and financial advice
- Twitter sued by advisory firm for not paying $1.9 mn as Musk deal fees
- Artist recycles e-waste from banks into 10-ft-tall statue
- Nine of top-10 firms add Rs 1.88 lakh cr in m-cap; ITC biggest gainer
- India biggest exporter of vaccines, mobile phones: Union Minister Thakur
- 'Waste to wonder' park coming up in Agra